Yang, Qiao
Zhang, Fujing
Hao, Zhixin
Zhuang, Junling
Huo, Li
Funding for this research was provided by:
the Capital Health Development Scientific Research Fund (Grant No. 2022-2-4013)
National High Level Hospital Clinical Research Funding (2022-PUMCH-B-048)
National High Level Hospital Clinical Research Funding (XH-QN-012K)
National High Level Hospital Clinical Research Funding (2022-PUMCH-D-001)
National Key Research and Development Program of China (2016YFC0901500)
CAMS innovation fund for medical science (CIFMS-2021-I2M-1-025)
CAMS innovation fund for medical science (CIFMS-2021-I2M-1-002)
CAMS innovation fund for medical science (CIFMS-2021-I2M-1-003)
National Natural Science Foundation of China (82071967)
Article History
Received: 17 May 2024
Revised: 5 September 2024
Accepted: 5 September 2024
First Online: 20 September 2024
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the institutional review board of Peking Union Medical College Hospital (ZS-2964) and registered at Clinicaltrial.gov (NCT05364177).
: Informed consent was obtained from all individual participants included in the study.
: The authors declare that they have no conflict of interest.